Lv1
55 积分 2022-07-03 加入
Inmunoterapia, cáncer y PET
2年前
已完结
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites
2年前
已关闭
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
2年前
已完结
ImmunoPET Imaging with 89Zr-labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
2年前
已完结
Implications of genetic heterogeneity in hepatocellular cancer
2年前
已完结
A pan‐cancer analysis identifies HDAC11 as an immunological and prognostic biomarker
2年前
已完结
Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review
2年前
已完结
Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment
2年前
已完结
Predictive biomarkers for programmed death-1/programmed death ligand immune checkpoint inhibitors in nonsmall cell lung cancer
2年前
已完结
Imaging response assessment of immunotherapy in patients with renal cell and urothelial carcinoma
2年前
已完结
皖公网安备34019202002308
